DTCFF
Price:
$0.3387
Market Cap:
$30.98M
Defence Therapeutics Inc., a biotechnology firm, is committed to the research and development of innovative biological and biosimilar therapeutic agents for both cancer and infectious diseases. Central to its strategy is the proprietary ACCUM™ technology platform, which ensures the precise and intact delivery of vaccine antigens or antibody-drug conjugates (ADCs) to their intended target cells. The company's development pipeline primarily concentrates on three key areas: dendritic cell-based cancer vaccines, protein-based vaccine formulations for COVID-19 and other infectious illnesses, and various antibody-drug conjugate (ADC) products designed to address different cancers. Founded in 2017,...[Read more]
Industry
Biotechnology
IPO Date
2021-05-18
Stock Exchange
OTC
Ticker
DTCFF
According to Defence Therapeutics Inc.’s latest financial reports and current stock price. The company's current ROE is -1661.38%. This represents a change of -3237.68% compared to the average of 52.95% of the last 4 quarters.
The mean historical ROE of Defence Therapeutics Inc. over the last ten years is 664.74%. The current -1661.38% ROE has changed -349.93% with respect to the historical average. Over the past ten years (40 quarters), DTCFF's ROE was at its highest in in the September 2019 quarter at 8.83%. The ROE was at its lowest in in the March 2022 quarter at -111.91%.
Average
664.74%
Median
280.46%
Minimum
-431.80%
Maximum
2.63%
Discovering the peaks and valleys of Defence Therapeutics Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 44.26%
Maximum Annual ROE = 2.63%
Minimum Annual Increase = -3736.44%
Minimum Annual ROE = -431.80%
| Year | ROE | Change |
|---|---|---|
| 2025 | 280.46% | -23.81% |
| 2024 | 368.09% | -185.24% |
| 2023 | -431.80% | -122.79% |
| 2022 | 1.89% | -3736.44% |
| 2021 | -52.11% | 44.26% |
| 2020 | -36.12% | -101.37% |
The current ROE of Defence Therapeutics Inc. (DTCFF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
72.25%
5-year avg
411.91%
10-year avg
664.74%
Defence Therapeutics Inc.’s ROE is less than Provectus Biopharmaceuticals, Inc. (89.65%), less than Sernova Corp. (55.85%), less than MedMira Inc. (15.28%), greater than Cynata Therapeutics Limited (-179.37%), greater than Microbix Biosystems Inc. (-21.02%), less than Starpharma Holdings Limited (-15.96%), greater than Celyad Oncology S.A. (-242.11%), greater than Bonus BioGroup Ltd. (-1541.00%), less than WOWI, Inc. (157.95%), greater than Finch Therapeutics Group, Inc. (-86.83%),
| Company | ROE | Market cap |
|---|---|---|
| 89.65% | $26.06M | |
| 55.85% | $39.76M | |
| 15.28% | $34.17M | |
| -179.37% | $54.17M | |
| -21.02% | $30.11M | |
| -15.96% | $206.25M | |
| -242.11% | $11.19M | |
| -1541.00% | $151.83M | |
| 157.95% | $6.76K | |
| -86.83% | $12.04M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Defence Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Defence Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Defence Therapeutics Inc.'s ROE?
How is the ROE calculated for Defence Therapeutics Inc. (DTCFF)?
What is the highest ROE for Defence Therapeutics Inc. (DTCFF)?
What is the 3-year average ROE for Defence Therapeutics Inc. (DTCFF)?
What is the 5-year average ROE for Defence Therapeutics Inc. (DTCFF)?
How does the current ROE for Defence Therapeutics Inc. (DTCFF) compare to its historical average?